Sign Up to like & get
recommendations!
0
Published in 2025 at "Clinical Rheumatology"
DOI: 10.1007/s10067-025-07529-2
Abstract: The recombinant zoster vaccine (Shingrix) was recently approved for the prevention of herpes zoster reactivation in adults aged ≥ 50 years. While its effectiveness has been widely demonstrated, its safety profile and potential adverse effects remain uncertain.…
read more here.
Keywords:
lupus;
induced lupus;
lupus induced;
drug ... See more keywords